F-Star GmbH reorganises

Monday 14 May 2012

F-Star GmbH, an antibody discovery company, has changed its top management and expanded its operations in Cambridge, UK in preparation for the advance of its bispecific antibody platform to the clinic. CEO Kevin FitzGerald is stepping down.

Full text available to subscribers only. Click here for information on subscribing to MedNous.

Location

Austria